Consolidating KMS-11 as our primary experimental model for investigating the role of p52 in multiple myeloma, we identified several p52-regulated essential genes upregulated in patients, i.e. RGS1 and RHEB, whose expression have been linked to poorer prognosis in MM patients and other cancers53,54. The gene discussed is RGS1; the disease is plasma cell myeloma.